PHS
EXP icon

PFM Health Sciences’s Eagle Materials EXP Stock Holding History

PFM Health Sciences’s Portfolio EXP Stock Details EXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-586,800
Closed -$40.1M – 72
2015
Q3 		$40.1M Sell
586,800
-418,939
-42% -$32.7M 1.13% 32
2015
Q2 		$76.8M Buy
1,005,739
+544,524
+118% +$45M 1.94% 17
2015
Q1 		$38.5M Buy
+461,215
New +$35.9M 1.06% 37

Other funds holding EXP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

PFM Health Sciences's EXP Position: Q4 2015 in Review

PFM Health Sciences sold out of Eagle Materials (EXP) in Q4 2015, closing a stake of 586,800 shares — an estimated $40.1M sold.

PFM Health Sciences first reported a position in EXP in Q1 2015 and held it in 3 quarters. The position peaked at $76.8M in Q2 2015. 242 funds tracked by Wall St. Rank hold EXP as of Q4 2015.

  • PFM Health Sciences reported no remaining Eagle Materials position as of Q4 2015 after selling out during the quarter.
  • PFM Health Sciences sold 586,800 Eagle Materials shares in Q4 2015, an estimated $40.1M.
  • PFM Health Sciences first reported a position in Eagle Materials in Q1 2015 and held it in 3 quarters.
  • PFM Health Sciences's Eagle Materials position peaked at $76.8M in Q2 2015.
  • 242 funds tracked by Wall St. Rank held Eagle Materials as of Q4 2015.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.